|
1
|
Heemskerk MH, Hoogeboom M, Hagedoorn R, et
al: Reprogramming of virus-specific T cells into leukemia-reactive
T cells using T cell receptor gene transfer. J Exp Med.
199:885–894. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hughes MS, Yu YY, Dudley ME, et al:
Transfer of a TCR gene derived from a patient with a marked
antitumor response conveys highly active T-cell effector functions.
Hum Gene Ther. 16:457–472. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abad JD, Wrzensinski C, Overwijk W, et al:
T-cell receptor gene therapy of established tumors in a murine
melanoma model. J Immunother. 31:1–6. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coccoris M, Swart E, de Witte MA, et al:
Long-term functionality of TCR-transduced T cells in vivo. J
Immunol. 180:6536–6543. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
de Witte MA, Bendle GM, van den Boom MD,
et al: TCR gene therapy of spontaneous prostate carcinoma requires
in vivo T cell activation. J Immunol. 181:2563–2571.
2008.PubMed/NCBI
|
|
6
|
Dossett ML, Teague RM, Schmitt TM, et al:
Adoptive immunotherapy of disseminated leukemia with
TCR-transduced, CD8+ T cells expressing a known
endogenous TCR. Mol Ther. 17:742–749. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morgan RA, Dudley ME, Wunderlich JR, et
al: Cancer regression in patients after transfer of genetically
engineered lymphocytes. Science. 314:126–129. 2006. View Article : Google Scholar
|
|
8
|
Johnson LA, Morgan RA, Dudley ME, et al:
Gene therapy with human and mouse T-cell receptors mediates cancer
regression and targets normal tissues expressing cognate antigen.
Blood. 114:535–546. 2009. View Article : Google Scholar
|
|
9
|
Bendle GM, Linnemann C, Hooijkaas AI, et
al: Lethal graft-versus-host disease in mouse models of T cell
receptor gene therapy. Nat Med. 16:565–570. 2010. View Article : Google Scholar
|
|
10
|
van Loenen MM, de Boer R, Amir AL, et al:
Mixed T cell receptor dimers harbor potentially harmful
neoreactivity. Proc Natl Acad Sci USA. 107:10972–10977.
2010.PubMed/NCBI
|
|
11
|
Cohen CJ, Zhao Y, Zheng Z, et al: Enhanced
antitumor activity of murine-human hybrid T-cell receptor (TCR) in
human lymphocytes is associated with improved pairing and TCR/CD3
stability. Cancer Res. 66:8878–8886. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sommermeyer D and Uckert W: Minimal amino
acid exchange in human TCR constant regions fosters improved
function of TCR gene-modified T cells. J Immunol. 184:6223–6231.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kuball J, Dossett ML, Wolfl M, et al:
Facilitating matched pairing and expression of TCR chains
introduced into human T cells. Blood. 109:2331–2338. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cohen CJ, Li YF, El-Gamil M, et al:
Enhanced antitumor activity of T cells engineered to express T-cell
receptors with a second disulfide bond. Cancer Res. 67:3898–3903.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Voss RH, Willemsen RA, Kuball J, et al:
Molecular design of the Cαβ interface favors specific pairing of
introduced TCRαβ in human T cells. J Immunol. 180:391–401.
2008.PubMed/NCBI
|
|
16
|
Willemsen R, Weijtens M, Ronteltap C, et
al: Grafting primary human T lymphocytes with cancer-specific
chimeric single chain and two chain TCR. Gene Ther. 7:1369–1377.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang T, He X, Tsang TC, et al: Transgenic
TCR expression: comparison of single chain with full-length
receptor constructs for T-cell function. Cancer Gene Ther.
11:487–496. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schaft N, Lankiewicz B, Drexhage J, et al:
T cell re-targeting to EBV antigens following TCR gene transfer:
CD28-containing receptors mediate enhanced antigen-specific IFNγ
production. Int Immunol. 18:591–601. 2006.PubMed/NCBI
|
|
19
|
Wu F, Zhang W, Shao H, et al: Human
effector T cells derived from central memory cells rather than
CD8+ T cells modified by tumor-specific TCR gene
transfer possess superior traits for adoptive immunotherapy. Cancer
Lett. 339:195–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shao H, Zhang W, Hu Q, et al: TCR
mispairing in genetically modified T cells was detected by
fluorescence resonance energy transfer. Mol Biol Rep. 37:3951–3956.
2010. View Article : Google Scholar
|
|
21
|
Schroers R, Hildebrandt Y, Hasenkamp J, et
al: Gene transfer into human T lymphocytes and natural killer cells
by Ad5/F35 chimeric adenoviral vectors. Exp Hematol. 32:536–546.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Elangovan M, Wallrabe H, Chen Y, et al:
Characterization of one-and two-photon excitation fluorescence
resonance energy transfer microscopy. Methods. 29:58–73. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wallrabe H and Periasamy A: Imaging
protein molecules using FRET and FLIM microscopy. Curr Opin
Biotech. 16:19–27. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Call ME, Wucherpfennig KW and Chou JJ: The
structural basis for intramembrane assembly of an activating
immunoreceptor complex. Nat Immunol. 11:1023–1029. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuhns MS, Girvin AT, Klein LO, et al:
Evidence for a functional sidedness to the αβTCR. Proc Natl Acad
Sci USA. 107:5094–5099. 2010.
|
|
26
|
Call ME, Schnell JR, Xu C, et al: The
structure of the ζζ transmembrane dimer reveals features essential
for its assembly with the T cell receptor. Cell. 127:355–368.
2006.
|
